Federated Hermes
ALT icon

Federated Hermes’s Altimmune ALT Stock Holding History

Federated Hermes’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-75
Closed -$283 – 2071
2025
Q3 		$283 Sell
75
-915,383
-100% -$3.53M ﹤0.01% 2104
2025
Q2 		$3.54M Buy
915,458
+727,731
+388% +$3.94M 0.01% 813
2025
Q1 		$939K Buy
+187,727
New +$1.19M ﹤0.01% 1122
2024
Q1 		– Sell
-121
Closed -$1.36K – 2028
2023
Q4 		$1.36K Sell
121
-2,014
-94% -$8.41K ﹤0.01% 1954
2023
Q3 		$5.55K Buy
2,135
+1,927
+926% +$5.53K ﹤0.01% 1875
2023
Q2 		$734 Sell
208
-732
-78% -$3.29K ﹤0.01% 2037
2023
Q1 		$3.97K Buy
+940
New +$11.2K ﹤0.01% 1953
2020
Q1 		– Sell
-370
Closed -$1K – 2237
2019
Q4 		$1K Buy
370
+223
+152% +$412 ﹤0.01% 2062
2019
Q3 		$1K Buy
+147
New +$326 ﹤0.01% 2067

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Federated Hermes's ALT Position: Q4 2025 in Review

Federated Hermes sold out of Altimmune (ALT) in Q4 2025, closing a stake of 75 shares — an estimated $283 sold.

Federated Hermes first reported a position in ALT in Q3 2019 and held it in 9 quarters. The position peaked at $3.54M in Q2 2025. 181 funds tracked by Wall St. Rank hold ALT as of Q4 2025.

  • Federated Hermes reported no remaining Altimmune position as of Q4 2025 after selling out during the quarter.
  • Federated Hermes sold 75 Altimmune shares in Q4 2025, an estimated $283.
  • Federated Hermes first reported a position in Altimmune in Q3 2019 and held it in 9 quarters.
  • Federated Hermes's Altimmune position peaked at $3.54M in Q2 2025.
  • 181 funds tracked by Wall St. Rank held Altimmune as of Q4 2025.

Based on Federated Hermes's 13F filing for Q4 2025, filed 12 Feb 2026.